ritanserin has been researched along with oxidopamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Matsumoto, K; Mizowaki, M; Murakami, Y; Thongpraditchote, S; Watanabe, H | 1 |
| Furukawa, H; Kamei, H; Mamiya, T; Miyamoto, Y; Nabeshima, T; Noda, Y | 1 |
| Basura, GJ; Walker, PD | 1 |
| Bishop, C; Kamdar, DP; Walker, PD | 1 |
| Ali, U; Chen, L; Gui, ZH; Hui, YP; Liu, J; Wang, S; Wang, Y; Wu, ZH; Zhang, QJ | 1 |
6 other study(ies) available for ritanserin and oxidopamine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Drug Evaluation, Preclinical; Fenclonine; Head Movements; Ketanserin; Male; Mice; Mice, Inbred Strains; Norepinephrine; Oxidopamine; Ritanserin; Serotonin; Serotonin Antagonists | 1997 |
Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly.
Topics: alpha-Methyltyrosine; Animals; Benzazepines; Cocaine; Conditioning, Psychological; Male; Mice; Oxidopamine; Phencyclidine; Receptors, Dopamine D1; Receptors, Serotonin; Ritanserin | 1998 |
Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Enkephalins; Gene Expression Regulation; Hydroxyindoleacetic Acid; In Situ Hybridization; Ketanserin; Male; Neurons; Oxidopamine; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sympatholytics; Tachykinins; Transcription, Genetic | 2001 |
Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Benzazepines; Denervation; Dopamine; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Hyperkinesis; Male; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Ritanserin; Serotonin; Serotonin Antagonists | 2003 |
In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease.
Topics: Action Potentials; Amphetamines; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; GABA Antagonists; gamma-Aminobutyric Acid; Interneurons; Male; Oxidopamine; Parkinson Disease; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Ritanserin; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Sympatholytics; Synaptic Transmission | 2009 |